Five Billion-Dollar Deals in 45 Days: Inside the Cardiac Monitoring Gold Rush with Ken Nelson
In this episode of The Crux of Cardio, Jordan Burgin sits down with Ken Nelson, one of the most experienced commercial leaders in cardiac digital health.
Ken helped scale commercial teams at iRhythm, BioTelemetry/CardioNet, and Bardy Diagnostics, three of the defining names in ambulatory cardiac monitoring. He shares the inside story behind the 2020–2021 cardiac monitoring M&A wave, including Philips’ acquisition of BioTelemetry, Hillrom’s acquisition of BardyDx, and Boston Scientific’s acquisition of Preventice.
The conversation also covers the Medicare reimbursement shock that nearly…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.